California cannabis attorney Shay Aaron Gilmore examines consolidation, regulatory pressure, and distressed exits in his new article.

California AB 2249 defines "attractive to children" for cannabis packaging effective January 1, 2028. A California cannabis lawyer explains what the Senate stripped out.

Governor Newsom has until September 30 to sign or veto every cannabis bill of the 2026 California legislative session. AB 2249 is law. Seven bills wait on the desk — including SB 1272, which is drawin...

DCC's Summer 2026 rulemaking implements SB 1064 and AB 179. What the § 15002 and § 15003 amendments will include.

Since 2024, California cities can fine landlords and tenants $10,000 a day for unlicensed cannabis activity. Here's what AB 1684 requires.

When federal § 781 takes effect, intoxicating hemp becomes illegal. Does California AB 8 save your business? California hemp lawyer explains the off-ramp.

California's June 4, 2026 emergency rule lets a dual-designated A and M retailer hold each license in a separate entity on the same premises.

Distressed California cannabis firms can't file federal bankruptcy—even after 2026 rescheduling. How workouts, ABCs, and receiverships work under state law.

The federal hemp ban takes effect Nov. 12, 2026 — but WARN Act notice may be due Sept. 13. Why California hemp employers can't wait, and can't claim surprise.

Cannabis 280E relief examined: who keeps the disputed $1.6 billion in prior-year tax — large operators or the U.S. Treasury.

California's hemp beverage enforcement numbers look like a win. A clear-eyed look at where the trade moved—and the July 1, 2026 shift.

How marijuana rescheduling and Section 280E reshape entity choice, ownership, and compliance for California cannabis and hemp businesses.

The April 22 rescheduling order moves medical marijuana to Schedule III. What California dual A/M operators should watch before June 29.

Cannabis attorney Shay Gilmore analyzes DCC rulemakings — pesticide testing, multipack goods, METRC reform, AB 8 implementation, and more.

The DOJ's April 2026 order reschedules medical cannabis to Schedule III. Here's what California M-license operators and investors must do before June 22, 2026.

A California cannabis attorney's field report: local enforcement, Iran fuel costs, M&A deal structures, and national pricing data. Read the full analysis.

California's AB 8 zero-THC rule blocks most hemp products from the new CMS Substance Access BEI Medicare pilot. Attorney Shay Aaron Gilmore analyzes the legal conflict and what ACOs, hemp businesses, ...

From odor scrubber deadlines in Carpinteria to tax hikes in Redding and Santa Barbara, California's cannabis regulatory landscape is shifting fast. Attorney Shay Aaron Gilmore breaks down what license...

From DCC enforcement actions and CCAP appeals to multipack rulemaking and multi-agency compliance, here's what's happening right now in California cannabis administrative law — and what it means for y...

Recent legal and industry developments and what they mean for the California cannabis and hemp industries, both investors and operators.

California lawmakers have introduced over a dozen cannabis and hemp bills this session, largely refining the legislative framework signed into law in 2025.

This article examines the evolving legal framework governing cannabis issues in family court proceedings in California.

California cannabis M&A activity in 2026 will unfold against a backdrop of converging regulatory shifts at both the federal and state levels.

On January 2, 2026, the California Department of Food and Agriculture released its proposed amendments to the Cannabis Appellations Program.

2025 California Cannabis Litigation and Case Law: DCC Loss in Track-and-Trace Case Headlines Year of Court Decisions

Rescheduling marijuana may fix a broadly-condemned tax burden affecting cannabis businesses, but rescheduling allows problems to persist.

Shay will present a review of the 2025 California laws impacting cannabis and hemp, focused on major legislative developments.

The November 2025 federal ban on hemp-derived THC products, signed into law as part of the government spending bill last week, will meet California’s AB 8 (Aguiar-Curry) signed into California law by ...

Declining revenue, tax delinquencies, public corruption, and other challenges beset the Southern California cannabis industry.

A look at the cannabis laws of the 2025 California Legislative Session, including the two cannabis bills the governor vetoed

The five-year legal showdown between Catalyst Cannabis and California’s Department of Cannabis Control (DCC) over supply chain diversion is finally approaching a critical trial—one that could fundamen...

Rolls backs 25% hike that took effect 7/1 and pauses future increases until 6/30/28

California lawmakers have sent five cannabis bills to the Governor this session, including an excise tax rollback, and hemp integration.

With federal rescheduling rumors circulating, and the California Senate Appropriations Committee moving a crucial cannabis excise tax rollback measure to a vote on the California Senate floor, recent ...

A split panel of the U.S. Court of Appeals for the Second Circuit has found that the dormant Commerce Clause applies to state cannabis regimes.

As southern California jurisdictions continue expanding cannabis commerce, some northern California communities continue to face challenges.

California lawmakers moved several cannabis and hemp bills through Assembly and Senate policy committees before adjourning for Summer Recess.

Under the proposed rule, most of the industrial hemp Emergency Regulations adopted in September 2024 would be made permanent.

Shay will moderate a panel of cannabis law and policy experts at next week's Cannabis Law Institute in Denver, Colorado.

California lawmakers have moved bills addressing cannabis and hemp through the initial policy committee votes of the 2025 Legislative Session.

California's Department of Cannabis Control will hold a public hearing on Tuesday regarding cultivation updates and sanitation rules.

In a decision sure to be celebrated and cited by the plaintiffs’ bar, last week, by a 5-4 vote, the United States Supreme Court held, in Medical Marijuana, Inc. v. Horn, that “a plaintiff may seek tre...